However, according to the bidirectional MR analysis, ACP5, CPB2, GSTM3, NTNG1 and FMA171B obtained reliable changes when SCLC occurred, indicating their capabilities as biomarkers for SCLC. This evidence concerns the gene GSTM3 and small cell lung carcinoma.